Asthma Drugs Market Size, Competitors & Forecast to 2032

The asthma drugs market is rapidly transforming as industry stakeholders adapt to changing patient demands, tighter regulatory oversight, and innovative therapeutic approaches. This analysis equips senior leaders with strategic knowledge to anticipate emerging opportunities and manage critical risks across the market landscape.

Market Snapshot: Asthma Drugs Market Growth and Trajectory

The global asthma drugs market expanded from USD 25.75 billion in 2025 to USD 27.31 billion in 2026, and is projected to reach USD 39.62 billion by 2032, with a CAGR of 6.34%. Growth is supported by sustained innovation in biologic therapies, increasing adoption of digital health solutions, shifts in patient management practices, and evolving payer reimbursement models. The market demonstrates strong momentum, underpinned by new therapeutic classes and technology-driven approaches to asthma care.

Scope & Segmentation of the Asthma Drugs Market

Product Types: Inhalers, nebulizers, tablets, and oral formulations are tailored to distinct therapeutic needs, directly influencing patient compliance and ease of use across demographics.
Drug Classes: Includes albuterol, beta agonists, bronchodilators, corticosteroids, and leukotriene modifiers, each addressing specific severity levels and facilitating a range of clinical pathways for streamlined decision-making.
Delivery Modes: Inhalable therapies and oral options present unique requirements for device selection, technique training, and optimization of drug absorption profiles.
Distribution Channels: Hospital pharmacies, retail pharmacies, and online channels influence accessibility, pricing strategies, and education for patients and healthcare professionals.
End User Settings: Home care, ambulatory surgery centers, and acute care hospitals impact adoption, workflow integration, and reimbursement complexity.
Key Regions: Americas, Europe, Middle East and Africa, and Asia Pacific, each contributing distinctive regulatory approaches, market demand, and competitive pressures.
Emerging Technologies: Smart inhaler technology, remote health monitoring, and advanced biologics manufacturing platforms enhance therapeutic efficacy, support adherence, and differentiate market offerings for providers and payers.

Key Takeaways for Asthma Drugs Market Stakeholders

Biologic and precision-based treatments are transforming severe asthma care and prompting innovative commercial strategies that align with complex stakeholder expectations.
Digital health solutions, such as smart inhalers and connected monitoring, are improving patient engagement and enabling payers to support outcomes-focused reimbursement models.
Real-world evidence and pharmacovigilance are now central to regulatory requirements, compelling drug developers to prioritize practical endpoints and continuous outcome measurement.
Manufacturers increasingly diversify supply chains, emphasizing regionalized production and agile procurement to promote business continuity and minimize tariff exposure.
Strategic collaborations with contract manufacturers, technology innovators, and in-market distributors help companies shorten product introduction cycles while enhancing supply reliability.
Targeted market access strategies and adaptable pricing models are crucial for successfully navigating regional payer frameworks and maximizing product uptake.

Tariff Impact: U.S. Tariff Environment and Supply Chain Strategy

Recent U.S. tariffs introduced in 2025 have altered the global asthma drug supply chain, leading manufacturers to reassess raw material sourcing and finished goods procurement. These adjustments are driving a shift toward localized manufacturing processes, enhanced buffer stock strategies, and greater reliance on regional supply hubs. Companies are also initiating new pricing negotiations with payers in response to increased cost pressures, while reinforcing supplier relationships to sustain operational resilience. These shifts present operational challenges but also open opportunities for contract manufacturers and supply logistics partners.

Research Methodology & Data Sources

This report utilizes primary research with interviews from clinical, regulatory, and commercial experts, supplemented by insights from healthcare providers and payers. Secondary research draws on peer-reviewed studies, regulatory filings, industry disclosures, and clinical trial registries. Findings are substantiated by triangulation and expert review, strengthening the reliability and replicability of the conclusions.

Why This Report Matters

Identifies where innovation and emerging technology adoption drive business advantage and inform capital allocation.
Enables senior leaders to align strategic planning with evolving stakeholder needs, regulatory updates, and implications of global trade shifts for market entry or expansion.
Equips decision-makers with actionable intelligence for optimizing commercial execution, accelerating partnership development, and refining R&D direction in a rapidly advancing policy landscape.

Conclusion

The asthma drugs market is entering a crucial period requiring coordination among clinical, commercial, and operational teams. In-depth understanding of technology trends, stakeholder priorities, and regional conditions will be key to sustaining competitive performance and delivering meaningful therapeutic impacts.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Asthma Drugs Market, by Product Type

8.1. Inhalers
8.2. Nebulizers
8.3. Tablets & Pills

9. Asthma Drugs Market, by Drug Class

9.1. Albuterol
9.2. Beta Agonists
9.3. Brochodilators
9.4. Corticosteroids
9.5. Leukotriene Modifiers

10. Asthma Drugs Market, by Delivery Mode

10.1. Inhalable
10.2. Oral

11. Asthma Drugs Market, by Distribution Channel

11.1. Hospital Pharmacies
11.2. Online Pharmacies
11.3. Retail Pharmacies

12. Asthma Drugs Market, by End Users

12.1. Ambulatory Surgery Centers
12.2. Home Care Settings
12.3. Hospitals & Clinics

13. Asthma Drugs Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Asthma Drugs Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Asthma Drugs Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Asthma Drugs Market
17. China Asthma Drugs Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. ALK-Abelló A/S
18.6. Amphastar Pharmaceuticals, Inc.
18.7. AstraZeneca PLC
18.8. Bayer AG
18.9. Boehringer Ingelheim International GmbH
18.10. CHIESI Farmaceutici S.p.A.
18.11. Cipla Limited
18.12. Dr.Reddy’s Laboratories Ltd
18.13. F. Hoffmann-La Roche Ltd.
18.14. GlaxoSmithKline PLC
18.15. Hetero Labs Limited
18.16. Lallemand Inc.
18.17. Merck KGaA
18.18. Mundipharma International Limited
18.19. NIOX Group PLC
18.20. Novartis AG
18.21. Novo Holdings
18.22. OPKO Health, Inc.
18.23. Pfizer Inc.
18.24. Sanner GmbH
18.25. Sanofi S.A.
18.26. Sunovion Pharmaceuticals Inc.
18.27. Teva Pharmaceutical Industries Ltd.
18.28. Verona Pharma PLC
18.29. Viatris, Inc.

List of Figures

FIGURE 1. GLOBAL ASTHMA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ASTHMA DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ASTHMA DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ASTHMA DRUGS MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ASTHMA DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ASTHMA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ASTHMA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ASTHMA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ASTHMA DRUGS MARKET SIZE, BY INHALERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY INHALERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ASTHMA DRUGS MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ASTHMA DRUGS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ASTHMA DRUGS MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ASTHMA DRUGS MARKET SIZE, BY TABLETS & PILLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY TABLETS & PILLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ASTHMA DRUGS MARKET SIZE, BY TABLETS & PILLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ALBUTEROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ALBUTEROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ALBUTEROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ASTHMA DRUGS MARKET SIZE, BY BETA AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ASTHMA DRUGS MARKET SIZE, BY BETA AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ASTHMA DRUGS MARKET SIZE, BY BETA AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ASTHMA DRUGS MARKET SIZE, BY BROCHODILATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ASTHMA DRUGS MARKET SIZE, BY BROCHODILATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ASTHMA DRUGS MARKET SIZE, BY BROCHODILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ASTHMA DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ASTHMA DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ASTHMA DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LEUKOTRIENE MODIFIERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LEUKOTRIENE MODIFIERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LEUKOTRIENE MODIFIERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ASTHMA DRUGS MARKET SIZE, BY INHALABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ASTHMA DRUGS MARKET SIZE, BY INHALABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ASTHMA DRUGS MARKET SIZE, BY INHALABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ASTHMA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ASTHMA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ASTHMA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ASTHMA DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS ASTHMA DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 80. EUROPE ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. EUROPE ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. EUROPE ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 83. EUROPE ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 84. EUROPE ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. EUROPE ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 86. MIDDLE EAST ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. MIDDLE EAST ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. MIDDLE EAST ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 92. AFRICA ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 94. AFRICA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 95. AFRICA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 96. AFRICA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. AFRICA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ASTHMA DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. ASEAN ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. ASEAN ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. ASEAN ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 108. ASEAN ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 109. ASEAN ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. ASEAN ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 111. GCC ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GCC ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. GCC ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 114. GCC ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 115. GCC ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. GCC ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 117. EUROPEAN UNION ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. EUROPEAN UNION ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 123. BRICS ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. BRICS ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. BRICS ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 126. BRICS ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 127. BRICS ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. BRICS ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 129. G7 ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. G7 ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. G7 ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 132. G7 ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 133. G7 ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. G7 ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 135. NATO ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. NATO ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. NATO ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 138. NATO ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 139. NATO ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. NATO ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. UNITED STATES ASTHMA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 143. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 144. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 145. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 146. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 148. CHINA ASTHMA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 149. CHINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. CHINA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 151. CHINA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 152. CHINA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. CHINA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Asthma Drugs market report include:

ALK-Abelló A/S
Amphastar Pharmaceuticals, Inc.
AstraZeneca PLC
Bayer AG
Boehringer Ingelheim International GmbH
CHIESI Farmaceutici S.p.A.
Cipla Limited
Dr.Reddy’s Laboratories Ltd
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PLC
Hetero Labs Limited
Lallemand Inc.
Merck KGaA
Mundipharma International Limited
NIOX Group PLC
Novartis AG
Novo Holdings
OPKO Health, Inc.
Pfizer Inc.
Sanner GmbH
Sanofi S.A.
Sunovion Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
Verona Pharma PLC
Viatris, Inc.

Table Information

Report Attribute	Details
No. of Pages	181
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 27.31 Billion
Forecasted Market Value ( USD ) by 2032	$ 39.62 Billion
Compound Annual Growth Rate	6.3%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3458EUR$3,939USD£2,992GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3730EUR$4,249USD£3,227GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5056EUR$5,759USD£4,374GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6118EUR$6,969USD£5,293GBP

Asthma Drugs Market - Global Forecast 2026-2032

Market Snapshot: Asthma Drugs Market Growth and Trajectory

Scope & Segmentation of the Asthma Drugs Market

Key Takeaways for Asthma Drugs Market Stakeholders

Tariff Impact: U.S. Tariff Environment and Supply Chain Strategy

Research Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Asthma Drugs Market Growth and Trajectory

Scope & Segmentation of the Asthma Drugs Market

Key Takeaways for Asthma Drugs Market Stakeholders

Tariff Impact: U.S. Tariff Environment and Supply Chain Strategy

Research Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Asthma Therapeutics Market - Global Forecast 2026-2032

COPD and Asthma Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti-Inflammatory, Bronchodilators), Device/Product (Inhalers), Technology/Software, Indication, Distribution Channel, and Region with Growth Forecasts, 2025-2030

Asthma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Asthma Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis

Asthma Drugs - Global Strategic Business Report

About the Asthma Treatment Market